EPG-HU1418-201 - Clinical Trial
Who Can Participate in the Study?
Age Group
Children
Study Details
Full Title
EPG-HU1418-201: A Phase 2/3 Study to Characterize and Evaluate the Efficacy, Safety, and Tolerability of hu14.18K322A Treatment Given in Combination with Chemotherapy in Participants with High-Risk Neuroblastoma
Principal Investigator
Jessica M. Sun, MD
Pediatric Hematology-Oncology Specialist
Protocol Number
IRB:
PRO00119566
NCT:
NA
Phase
Phase II/III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment